Your browser doesn't support javascript.
loading
Recent vaccine technology in industrial animals
Article in English | WPRIM (Western Pacific) | ID: wpr-8378
Responsible library: WPRO
ABSTRACT
Various new technologies have been applied for developing vaccines against various animal diseases. Virus-like particle (VLP) vaccine technology was used for manufacturing the porcine circovirus type 2 and RNA particle vaccines based on an alphavirus vector for porcine epidemic diarrhea (PED). Although VLP is classified as a killed-virus vaccine, because its structure is similar to the original virus, it can induce long-term and cell-mediated immunity. The RNA particle vaccine used a Venezuela equine encephalitis (VEE) virus gene as a vector. The VEE virus partial gene can be substituted with the PED virus spike gene. Recombinant vaccines can be produced by substitution of the target gene in the VEE vector. Both of these new vaccine technologies made it possible to control the infectious disease efficiently in a relatively short time.
Subject(s)

Full text: Available Health context: SDG3 - Health and Well-Being Health problem: Target 3.3: End transmission of communicable diseases Database: WPRIM (Western Pacific) Main subject: Venezuela / RNA / Vaccines / Vaccines, Synthetic / Communicable Diseases / Circovirus / Alphavirus / Diarrhea / Encephalitis Virus, Venezuelan Equine / Encephalomyelitis, Equine Limits: Animals Country/Region as subject: South America / Venezuela Language: English Journal: Clinical and Experimental Vaccine Research Year: 2016 Document type: Article
Full text: Available Health context: SDG3 - Health and Well-Being Health problem: Target 3.3: End transmission of communicable diseases Database: WPRIM (Western Pacific) Main subject: Venezuela / RNA / Vaccines / Vaccines, Synthetic / Communicable Diseases / Circovirus / Alphavirus / Diarrhea / Encephalitis Virus, Venezuelan Equine / Encephalomyelitis, Equine Limits: Animals Country/Region as subject: South America / Venezuela Language: English Journal: Clinical and Experimental Vaccine Research Year: 2016 Document type: Article
...